Effect of High-flow Nasal Cannula Oxygen on Lung Volumes Determined by Electrical Impedance Tomography (OXIDIA)

July 23, 2015 updated by: University Hospital, Clermont-Ferrand
Effect of High-flow nasal cannula oxygen on end-expiratory lung volumes determined by electrical impedance tomography

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Prospective clinical study in ICU with patients requiring High-flow nasal cannula oxygen comparing lung volumes determined by electrical impedance tomography and diaphragmatic ultrasound before, during and after High-flow nasal cannula oxygen.

Duration of High-flow nasal cannula oxygen is 30 minutes.

Study Type

Observational

Enrollment (Actual)

20

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • France
      • Clermont-Ferrand, France, 63003
        • CHU Clermont-Ferrand

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Adult ICU patients

Description

Inclusion Criteria:

  • • Adult ICU patients requiring High-flow nasal cannula oxygen

    • Consent of patients or family
    • Arterial line

Exclusion Criteria:

  • • Tracheotomized patients

    • Dressings in the thoracic area

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Adult ICU patients
Other: High-flow nasal cannula oxygen

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
End-expiratory lung volume (EELV) determined by electrical impedance tomography before NIV non invasive ventilation
Time Frame: at day 1
at day 1
End-expiratory lung volume (EELV) determined by electrical impedance tomography during NIV non invasive ventilation
Time Frame: at day 1
at day 1
End-expiratory lung volume (EELV) determined by electrical impedance tomography after NIV non invasive ventilation
Time Frame: at day 1
at day 1

Secondary Outcome Measures

Outcome Measure
Time Frame
Anterior, medio-anterior, medio-posterior and posterior EELV at each time
Time Frame: at day 1
at day 1
Diaphragmatic excursion and thickness determined by ultrasound
Time Frame: at day 1
at day 1
Ventilatory frequency
Time Frame: at day 1
at day 1

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University Hospital, Clermont-Ferrand

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 1, 2014

Primary Completion (Actual)

October 1, 2014

Study Completion (Actual)

October 1, 2014

Study Registration Dates

First Submitted

June 20, 2014

First Submitted That Met QC Criteria

July 7, 2014

First Posted (Estimate)

July 10, 2014

Study Record Updates

Last Update Posted (Estimate)

July 24, 2015

Last Update Submitted That Met QC Criteria

July 23, 2015

Last Verified

July 1, 2015

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • CHU-0196

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Critical Care

Clinical Trials on High-flow nasal cannula oxygen

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uganda

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe